Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 5
1979 1
1981 4
1982 2
1983 1
1985 1
1991 1
1992 1
1994 4
1995 5
1996 2
1999 1
2000 2
2002 1
2003 2
2005 2
2006 2
2007 1
2009 1
2015 1
2016 2
2017 1
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Half-time bone scintigraphy in prostate and breast cancer patients.
Grootjans W, Serém SJ, Gomes MI, Heijmen L, Bulten BF, Mijnheere EP, Hermsen R, van den Broek WJ. Grootjans W, et al. Among authors: van den broek wj. Q J Nucl Med Mol Imaging. 2018 Sep;62(3):303-312. doi: 10.23736/S1824-4785.16.02830-2. Epub 2016 Feb 16. Q J Nucl Med Mol Imaging. 2018. PMID: 26883516
Cell membrane integrity in myotonic dystrophy type 1: implications for therapy.
González-Barriga A, Kranzen J, Croes HJ, Bijl S, van den Broek WJ, van Kessel ID, van Engelen BG, van Deutekom JC, Wieringa B, Mulders SA, Wansink DG. González-Barriga A, et al. Among authors: van den broek wj. PLoS One. 2015 Mar 23;10(3):e0121556. doi: 10.1371/journal.pone.0121556. eCollection 2015. PLoS One. 2015. PMID: 25799359 Free PMC article.
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.
Mulders SA, van den Broek WJ, Wheeler TM, Croes HJ, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, Wieringa B, Wansink DG. Mulders SA, et al. Among authors: van den broek wj. Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13915-20. doi: 10.1073/pnas.0905780106. Epub 2009 Aug 10. Proc Natl Acad Sci U S A. 2009. PMID: 19667189 Free PMC article.
CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing.
van Agtmaal EL, André LM, Willemse M, Cumming SA, van Kessel IDG, van den Broek WJAA, Gourdon G, Furling D, Mouly V, Monckton DG, Wansink DG, Wieringa B. van Agtmaal EL, et al. Among authors: van den broek wjaa. Mol Ther. 2017 Jan 4;25(1):24-43. doi: 10.1016/j.ymthe.2016.10.014. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129118 Free PMC article.
Increased response to cholesterol feeding in apolipoprotein C1-deficient mice.
van Ree JH, Hofker MH, van den Broek WJ, van Deursen JM, van der Boom H, Frants RR, Wieringa B, Havekes LM. van Ree JH, et al. Among authors: van den broek wj. Biochem J. 1995 Feb 1;305 ( Pt 3)(Pt 3):905-11. doi: 10.1042/bj3050905. Biochem J. 1995. PMID: 7848292 Free PMC article.
Clinical significance of low cobalamin levels in older hospital patients.
van Asselt DZ, Blom HJ, Zuiderent R, Wevers RA, Jakobs C, van den Broek WJ, Lamers CB, Corstens FH, Hoefnagels WH. van Asselt DZ, et al. Among authors: van den broek wj. Neth J Med. 2000 Aug;57(2):41-9. doi: 10.1016/s0300-2977(00)00048-6. Neth J Med. 2000. PMID: 10924940
44 results